BRAFV600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence

摘要

BackgroundPapillary thyroid cancer (PTC) recurrence risk is difficult to predict. No current risk classification system incorporates BRAF mutational status. Here, we assess the incremental value of BRAF mutational status in predicting PTC recurrence relative to existing recurrence risk algorithms.